Moolec Science SA (NASDAQ:MLEC) Short Interest Update

Moolec Science SA (NASDAQ:MLEC) saw a large decrease in short interest during the month of January. As of January 30th, there was short interest totaling 23,800 shares, a decrease of 36.9% from the January 15th total of 37,707 shares. Currently, 4.1% of the shares of the company are short sold. Based on an average daily trading volume, of 687,555 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily trading volume, of 687,555 shares, the days-to-cover ratio is currently 0.0 days. Currently, 4.1% of the shares of the company are short sold.

Institutional Trading of Moolec Science

An institutional investor recently bought a new position in Moolec Science stock. Citadel Advisors LLC purchased a new stake in Moolec Science SA (NASDAQ:MLEC) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned approximately 0.90% of Moolec Science at the end of the most recent reporting period. Institutional investors and hedge funds own 0.07% of the company’s stock.

Moolec Science Trading Up 72.2%

Shares of Moolec Science stock traded up $3.68 on Friday, reaching $8.78. 50,465,138 shares of the stock were exchanged, compared to its average volume of 386,781. The firm has a market capitalization of $6.37 million, a PE ratio of -0.27 and a beta of -0.46. Moolec Science has a 1-year low of $3.08 and a 1-year high of $157.05. The business has a fifty day moving average price of $5.25 and a two-hundred day moving average price of $13.83.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.